Positron Emission Tomography Imaging of Small Animals in Anticancer Drug Development

被引:0
作者
Eric O. Aboagye
机构
[1] Imperial College London,Molecular Therapy and PET Oncology Research group, The Clinical Sciences Centre, Faculty of Medicine, Hammersmith Hospital Campus
来源
Molecular Imaging and Biology | 2005年 / 7卷
关键词
Small animal imaging; PET; Anticancer; Drug development;
D O I
暂无
中图分类号
学科分类号
摘要
Positron emission tomography (PET) imaging of small animals enables researchers to bridge the gap between in vitro science and in vivo human studies. The imaging paradigm can be established and refined in animals before implementation in humans and image data related to ex vivo assays of biological activity. Small animal PET (saPET) imaging enables assessment of baseline focal pathophysiology, pharmacokinetics, biological target modulation and the efficacy of novel drugs. The potential and challenge of this technology as applied to anticancer drug development is discussed here.
引用
收藏
页码:53 / 58
页数:5
相关论文
共 118 条
[1]  
Myers R(2001)The biological application of small animal PET imaging Nucl Med Biol 28 585-593
[2]  
Hume SP(2002)Dedicated small animal scanners: A new tool for drug development Curr Pharm Des 8 1497-1511
[3]  
Myers R(1998)Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals Eur J Nucl Med 25 173-176
[4]  
Hume SP(1998)High-resolution 3D Bayesian image reconstruction using the micro-PET small-animal scanner Phys Med Biol 43 1001-1013
[5]  
Gunn RN(2002)4D PET with the quad-HIDAC: Development of dynamic list-mode EM image reconstruction IEEE Nucl Sci Symp Conf Rec 3 1716-1720
[6]  
Jones T(2003) selectivity, Br J Cancer 89 1327-1333
[7]  
Qi JY(2003) biodistribution and tumor uptake of annexin V radiolabelled with a positron emitting radioisotope Cancer Res 63 3791-3798
[8]  
Leary RM(2002)3′-deoxy-3′-[ Eur J Cancer 38 2094-2107
[9]  
Cherry SR(2003)F]Fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy Invest New Drugs 21 309-340
[10]  
Chatziioannou A(2003) with positron emission tomography Invest New Drugs 21 169-181